Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.
Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...
Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...
US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...
Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...